Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Original Contribution entitled “Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial” published in the July 14, 2015, issue of JAMA,1 an incorrect study drug dose appeared in a figure. In Figure 2, the starting patiromer dose reported as 16.2 in the x-axis for both stratum 1 and stratum 2 in both the left and the right plots should have appeared as 16.8. This article was corrected online.
Incorrect Dose in Figure. JAMA. 2015;314(7):731. doi:10.1001/jama.2015.9237
Create a personal account or sign in to: